Sarcoma | Tumor

CURE’s sarcoma page features the latest cancer news and updates on sarcoma Through articles, videos, podcasts, and more, CURE brings readers the insights of experts, cancer survivors, patients, and advocates to ensure everyone is up to date in sarcoma.

Chaos Theory: Understanding the Genetic Chaos of Soft Tissue Sarcoma

August 23rd 2016, 12:23am

Article

The 50 cancers under the umbrella of soft tissue sarcoma are marked by genetic chaos, and a growing understanding of these mutations may lead to new treatments.

Keytruda Looks Promising in Phase 2 Study of Sarcoma

August 16th 2016, 9:26pm

Article

Keytruda is showing benefit to some patients with sarcoma, according to interim results from a phase 2 trial.

Searching for Answers in the Treatment of Young Patients With Sarcoma

June 24th 2016, 10:05pm

Article

CURE spoke with Noah Federman about the prevalence and treatment of sarcomas in younger patients.

Olaratumab Continues to Progress in Treatment of Soft Tissue Sarcoma

May 6th 2016, 8:18pm

Article

The FDA granted olaratumab a priority review for some people with advanced soft tissue sarcoma (STS).

Sarcoma Foundation of America Uses a Multi-Faceted Approach to Fighting the Disease

March 8th 2016, 8:13pm

Article

When it comes to fighting sarcoma, the Sarcoma Foundation of America does not stop at fundraising.

When it Comes to Sarcoma, Second Opinions Matter

February 25th 2016, 1:25pm

Article

Though Early, T-Cell Therapy Making Strides in Treatment of Sarcoma

February 11th 2016, 3:13am

Article

The breakthrough designation will expedite the development and review of this novel T-cell therapy in synovial sarcoma.

FDA Approves Halaven for Advanced Liposarcoma

January 29th 2016, 5:24am

Article

The approval of Halaven was based on an improvement in overall survival (OS) in a phase 3 study.

Adding New Agent to Chemotherapy Boosts Survival in Small Trial of Soft Tissue Sarcoma

November 13th 2015, 8:32pm

Article

Based on this study, the monoclonal antibody is being investigated in an ongoing phase 3 study and has received an FDA Breakthrough Therapy Designation.

FDA Approves Yondelis in Soft Tissue Sarcoma

October 23rd 2015, 6:40pm

Article

The approval is based on results from the phase 3 ET743-SAR-3007 trial.